CviLux Corporation
TWSE:8103.TW
49.75 (TWD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,958.621 | 3,727.014 | 4,159.393 | 3,134.712 | 3,133.851 | 3,110.632 | 2,713.382 | 2,589.451 | 2,542.88 | 3,085.711 | 2,521.296 | 2,335.984 | 2,243.775 | 2,155.877 | 1,478.638 |
| Cost of Revenue
| 1,950.399 | 2,620.589 | 2,912.083 | 2,104.188 | 2,229.221 | 2,256.619 | 1,891.748 | 1,758.813 | 1,759.08 | 2,131.633 | 1,747.301 | 1,471.08 | 1,435.205 | 1,350.633 | 931.305 |
| Gross Profit
| 1,008.222 | 1,106.425 | 1,247.31 | 1,030.524 | 904.63 | 854.013 | 821.634 | 830.638 | 783.8 | 954.078 | 773.995 | 864.904 | 808.57 | 805.244 | 547.333 |
| Gross Profit Ratio
| 0.341 | 0.297 | 0.3 | 0.329 | 0.289 | 0.275 | 0.303 | 0.321 | 0.308 | 0.309 | 0.307 | 0.37 | 0.36 | 0.374 | 0.37 |
| Reseach & Development Expenses
| 135.884 | 115.875 | 89.557 | 103.586 | 69.157 | 41.227 | 24.817 | 24.247 | 25.058 | 35.482 | 20.933 | 18.902 | 17.552 | 17.857 | 17.664 |
| General & Administrative Expenses
| 347.073 | 345.651 | 336.388 | 309.821 | 309.197 | 285.475 | 256.589 | 233.722 | 396.691 | 274.057 | 249.413 | 231.212 | 218.502 | 210.233 | 188.434 |
| Selling & Marketing Expenses
| 226.889 | 272.02 | 257.215 | 230.334 | 239.617 | 255.37 | 226.646 | 215.737 | 194.864 | 204.421 | 187.254 | 169.063 | 136.245 | 138.103 | 106.309 |
| SG&A
| 573.962 | 617.671 | 593.603 | 540.155 | 548.814 | 540.845 | 483.235 | 449.459 | 591.555 | 478.478 | 436.667 | 400.275 | 354.747 | 348.336 | 294.743 |
| Other Expenses
| 0 | 142.178 | -29.096 | -33.448 | 18.232 | 71.175 | -32.792 | 39.006 | 112.677 | 76.596 | 43.394 | 6.367 | 3.814 | 1.906 | -0.313 |
| Operating Expenses
| 684.843 | 733.546 | 683.16 | 643.741 | 617.971 | 582.072 | 508.052 | 473.706 | 616.613 | 513.96 | 457.6 | 419.177 | 372.299 | 366.193 | 312.407 |
| Operating Income
| 297.059 | 523.192 | 535.052 | 363.099 | 304.891 | 271.941 | 313.582 | 356.932 | 167.187 | 440.118 | 316.395 | 445.727 | 436.271 | 439.051 | 234.926 |
| Operating Income Ratio
| 0.1 | 0.14 | 0.129 | 0.116 | 0.097 | 0.087 | 0.116 | 0.138 | 0.066 | 0.143 | 0.125 | 0.191 | 0.194 | 0.204 | 0.159 |
| Total Other Income Expenses Net
| 44.165 | 132.63 | -45.274 | -41.309 | -19.13 | 63.204 | -37.93 | 31.944 | 102.168 | 68.377 | 33.593 | -18.456 | -25.88 | -44.755 | -15.847 |
| Income Before Tax
| 341.224 | 503.979 | 507.421 | 344.279 | 285.761 | 335.145 | 275.652 | 388.876 | 269.355 | 508.495 | 349.988 | 427.271 | 410.391 | 394.296 | 219.079 |
| Income Before Tax Ratio
| 0.115 | 0.135 | 0.122 | 0.11 | 0.091 | 0.108 | 0.102 | 0.15 | 0.106 | 0.165 | 0.139 | 0.183 | 0.183 | 0.183 | 0.148 |
| Income Tax Expense
| 126.206 | 175.897 | 171.099 | 129.939 | 110.171 | 131.198 | 108.667 | 144.369 | 175.59 | 116.27 | 74.671 | 103.462 | 90.696 | 73.48 | 33.172 |
| Net Income
| 217.909 | 331.509 | 338.615 | 215.884 | 175.68 | 204.528 | 168.16 | 243.829 | 93.784 | 391.25 | 274.711 | 323.031 | 319.695 | 320.816 | 187.67 |
| Net Income Ratio
| 0.074 | 0.089 | 0.081 | 0.069 | 0.056 | 0.066 | 0.062 | 0.094 | 0.037 | 0.127 | 0.109 | 0.138 | 0.142 | 0.149 | 0.127 |
| EPS
| 2.76 | 4.2 | 4.29 | 2.7 | 2.16 | 2.51 | 2.07 | 3 | 1.16 | 4.98 | 3.53 | 4.3 | 4.44 | 4.59 | 2.88 |
| EPS Diluted
| 2.38 | 3.6 | 4.13 | 2.67 | 2.14 | 2.48 | 2.05 | 2.96 | 0.87 | 4.76 | 3.37 | 4 | 4.01 | 4.33 | 2.84 |
| EBITDA
| 599.162 | 767.366 | 754.946 | 566.198 | 483.155 | 478.362 | 401.111 | 522.368 | 416.505 | 642.388 | 467.767 | 519.752 | 513.726 | 506.346 | 330.442 |
| EBITDA Ratio
| 0.203 | 0.204 | 0.183 | 0.181 | 0.155 | 0.154 | 0.148 | 0.202 | 0.163 | 0.208 | 0.184 | 0.229 | 0.244 | 0.234 | 0.231 |